Interprotein Corporation

After Boardroom Intrigue, CureVac Joins Competitors In mRNA Vaccines Race German biotech CureVac AG is to launch Phase I trials of its COVID-19 vaccine candidate, making it the latest among a wave o

A few weeks into 2019 and there has already been one global industry-shaking event emanating from Japan - the formal completion in early January of Takeda Pharmaceutical Co. Ltd. 's huge $62bn acquis

A regular roundup of commercial stories appearing in Scrip ’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on th

The pharma division of the diversified Japanese chemicals and materials group Asahi Kasei has signed a collaborative research agreement with RaQualia Pharma aimed at the discovery of new therapeutics